PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.\', \'National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.\', \'CAS Key Laboratory of Molecular Virology and Immunology, Institute Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, 200031, China.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China. xiaogf@wh.iov.cn.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China. wangml@wh.iov.cn.\', \'National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China. zhongwu@bmi.ac.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12250-020-00288-1
?:doi
?:hasPublicationType
?:journal
  • Virologica Sinica
is ?:pmid of
?:pmid
?:pmid
  • 32910347
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.737
?:rankingScore_hIndex
  • 17
?:title
  • Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all